The Society of Hospital Pharmacists of Australia (SHPA) has welcomed a raft of recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC) to restrict the prescribing of opioids, including smaller pack sizes, as part of broader efforts to support appropriate use and reduce associated harms.